Gustavo Maegawa | Biochemistry | Innovative Research Award

Innovative Research Award

Gustavo Maegawa — Columbia University Irving Medical Center, United States

Gustavo Maegawa
Affiliation Columbia University Irving Medical Center
Country United States
Scopus ID 14522943200
Documents 54
Citations 2,549
h-index 25
Subject Area Biochemistry
Event International Research Awards
ORCID 0000-0001-6933-4138

Gustavo Maegawa is a physician-scientist and academic researcher affiliated with Columbia University Irving Medical Center. His documented academic work includes clinical genetics, genomics, lysosomal storage disorders, and biochemical research, with publications addressing inherited metabolic diseases and related molecular mechanisms. Bibliographic records supplied for this recognition profile report 54 documents, 2,549 citations, and an h-index of 25.[1]

Abstract

Gustavo Maegawa is a physician-scientist affiliated with Columbia University Irving Medical Center whose research spans clinical genetics, genomics, biochemical investigation, and lysosomal storage disorders. His academic record includes research addressing inherited metabolic diseases and molecular mechanisms relevant to rare disorders. Publicly indexed publications identify his participation in multidisciplinary studies involving disease mechanisms, screening, therapeutic development, and molecular characterization.[1][2] Bibliographic information supplied for this profile records 54 documents, 2,549 citations, and an h-index of 25. His research activity therefore provides a basis for recognition under an Innovative Research Award framework, particularly through sustained scholarly contribution and interdisciplinary biomedical investigation. Recent publications further demonstrate continued involvement in research on lysosomal and inherited metabolic disorders.[1]

Keywords

Gustavo Maegawa; Innovative Research Award; Columbia University Irving Medical Center; biochemistry; clinical genetics; genomics; lysosomal storage disorders; inherited metabolic diseases; rare diseases; biomedical research; translational research; molecular medicine.[1]

Introduction

Gustavo Maegawa is identified by Columbia University as an Associate Professor of Pediatrics with academic expertise in clinical genetics and genomics. His research has focused particularly on lysosomal storage disorders, a group of inherited metabolic conditions involving defects in cellular degradation pathways.[1]

Research Profile

The research profile associated with Gustavo Maegawa encompasses clinical genetics, genomics, biochemical research, and lysosomal storage disorders. Columbia University describes his research focus as including lysosomal storage disorders and his professional expertise as clinical genetics and genomics.[1]

Research Contributions

His publication record also includes research related to newborn screening for lysosomal storage disorders. A 2024 study examining screening for six lysosomal storage disorders in China included Maegawa as a co-author and identified Columbia University affiliations.[5]

Publications

Selected publications involving Gustavo Maegawa demonstrate a research emphasis on rare diseases, inherited metabolic disorders, molecular mechanisms, and translational biomedical investigation. The following examples are drawn from indexed bibliographic records and are presented as representative publications rather than as a complete bibliography.[1]

Research Impact

Beyond citation indicators, the subject areas represented in the publication record are relevant to clinical genetics and rare-disease research. Studies involving lysosomal storage disorders, genetic screening, molecular mechanisms, and potential therapeutic strategies demonstrate connections between laboratory investigation and clinically relevant questions.[3][5]

Award Suitability

The Innovative Research Award is aligned with a research profile demonstrating sustained scholarly activity and contributions to scientific investigation. Gustavo Maegawa’s documented work in clinical genetics, genomics, biochemical research, and lysosomal storage disorders provides a relevant academic basis for consideration under this recognition category.[1]

Conclusion

Gustavo Maegawa’s research profile reflects sustained involvement in clinical genetics, genomics, biochemistry, and lysosomal storage disorder research. His publications address clinically and biologically significant questions involving inherited metabolic diseases, screening, molecular mechanisms, and therapeutic investigation.[3][4]

References

  1. Begum, S., Hsueh, S.-C., Cheria, E. M. Y., et al. Sphingolipid-neutralizing molecular therapy reduces psychosine cytotoxicity in Krabbe disease. iScience, 29(3), 114808, 2026. DOI: https://doi.org/10.1016/j.isci.2026.114808
  2. Yi, M., Wang, Y., Gao, X., et al. Investigation of GALNS variants and genotype-phenotype correlations in a large cohort of patients with mucopolysaccharidosis type IVA. Journal of Inherited Metabolic Disease, 45(3), 593–604, 2022.
    https://doi.org/10.1002/jimd.12491
  3. Maegawa, G. H. B., Tropak, M. B., Buttner, J. D., Rigat, B. A., Fuller, M., Pandit, D., Tang, L., Kornhaber, G. J., Hamuro, Y., Clarke, J. T. R., & Mahuran, D. J. (2009). Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease. Journal of Biological Chemistry, 284(35), 23502–23516.
    https://doi.org/10.1074/jbc.M109.012393

  4. Santelices, J., Ou, M., Maegawa, G. H. B., et al. USP8 inhibition regulates autophagy flux and controls Salmonella infection. Frontiers in Cellular and Infection Microbiology, 13, 1070271, 2023.  https://doi.org/10.3389/fcimb.2023.1070271
  5. Mallack, E. J., Turk, B. R., Yan, H., Price, C., Demetres, M., Moser, A. B., Becker, C., Hollandsworth, K., Adang, L., Vanderver, A., & Van Haren, K. (2021). MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines. Journal of Inherited Metabolic Disease.
    https://doi.org/10.1002/jimd.12356 

Peter Hristov | Biochemistry | Editorial Board Member

Prof Dr. Peter Hristov | Biochemistry | Editorial Board Member

Institute of Biodiversity and Ecosystem Research – Bulgarian Academy of Sciences (IBER-BAS) | Bulgaria

Prof. Dr. Peter Ivanov Hristov is a distinguished Bulgarian molecular biologist and biochemist whose work has significantly advanced the understanding of animal genetic diversity, molecular phylogeny, and population structure in domestic and wild species. Currently serving as a Professor at the Institute of Biodiversity and Ecosystem Research (IBER) at the Bulgarian Academy of Sciences, he has built a rigorous academic career grounded in molecular genetics, evolutionary biology, and biodiversity conservation. Prof. Hristov earned his Master’s degree from Trakia University in 1999, followed by a Ph.D. in 2005 from the Institute of Biology and Immunology of Reproduction at BAS. Over the past decade, he has progressed through academic ranks, serving as Chief Assistant (2010–2015), Associate Professor (2015–2021), and Professor (2021–present), reflecting his longstanding contributions to the field. His primary research areas include biochemistry, molecular biology, molecular phylogeny, population structure studies, and taxonomic research, complemented by strong expertise in bioinformatics and the statistical processing of molecular data. His involvement in international scientific collaborations includes participation in the EU’s Sixth Framework Programme—DeLiver Project (2007–2011)—demonstrating his engagement in large-scale, interdisciplinary research initiatives. Prof. Hristov’s scientific output is extensive and influential. He has authored 83 scientific publications, 59 of which appear in impact-factor or indexed journals, accumulating over 665 citations, with an h-index of 13 (Scopus). Remarkably, in the last five years alone, he has produced 40 publications, all in indexed journals, underscoring his active and consistent research productivity. His work spans genetic differentiation in livestock breeds, molecular detection of bee pathogens, mitochondrial DNA analyses, and phylogenetic exploration across various species. Key recent studies include genetic structure analysis of Bulgarian goat and horse breeds (Diversity, 2024), molecular pathogen detection in honey bees (Veterinary Sciences, 2023), and mitochondrial sequencing contributions revealing domestication centers in horse lineages (Journal of Equine Veterinary Science, 2022). His research also provides crucial insights into livestock conservation, biodiversity monitoring, and the application of molecular tools in animal breeding and health management. Prof. Hristov is widely recognized in the scientific community, publishing internationally under the name Peter Hristov and maintaining active research profiles on Scopus, ResearchGate, and ORCID. His work continues to bridge molecular science and biodiversity conservation, reinforcing his role as a leading figure in genetic research within Bulgaria and beyond.

Profile: Orcid

Featured Publications

Radoslavov, G., Kalaydzhiev, G., Yordanov, G., Palova, N., Salkova, D., & Hristov, P. (2025). Genetic diversity of native Bulgarian sheep breeds based on the mitochondrial D-loop sequence analysis. Small Ruminant Research, 108, 107527.

Yordanov, G., Yordanov, T., Mehandjyiski, I., Radoslavov, G., Salkova, D., & Hristov, P. (2025). Population structure and genetic diversity among Shagya Arabian horse genealogical lineages in Bulgaria based on microsatellite genotyping. Veterinary Sciences, 12(8), 776.

Stoeva, D., Gencheva, D., Radoslavov, G., Hristov, P., Yordanova, R., & Beev, G. (2025). Novel DNA barcoding and multiplex PCR strategy for the molecular identification and mycotoxin gene detection of Fusarium spp. in maize from Bulgaria. Methods and Protocols, 8(4), 78.

Salkova, D., Balkanska, R., Shumkova, R., Lazarova, S., Radoslavov, G., & Hristov, P. (2024). Molecular detection and phylogenetic relationships of honey bee-associated viruses in bee products. Veterinary Sciences, 11(8), 369.

Yordanov, G., Kalaydzhiev, G., Palova, N., Salkova, D., Lozanova, L., Dundarova, H., Odjakova, T., Todorov, P., Radoslavov, G., & Hristov, P. (2024). Genetic differentiation and population structure of two Bulgarian local goat breeds using microsatellite markers. Diversity, 16(7), 388.

Hristov, P., Radoslavov, G., Mehandjyiski, I., Salkova, D., & Yordanov, G. (2024). Genetic diversity and population structure among Arabian horse genealogical lineages in Bulgaria. Diversity, 16(5), 281.

Kalaydzhiev, G., Palova, N., Dundarova, H., Lozanova, L., Mehandjyiski, I., Radoslavov, G., & Hristov, P. (2023). Mitochondrial diversity and phylogenetic relationship of eight native Bulgarian sheep breeds. Animals, 13(23), 3655.

 

Shohei Katsuya | Biology and Life Sciences | Excellence in Research Award

Mr. Shohei Katsuya | Biology and Life Sciences | Excellence in Research Award

OSAKA GAS Co., Ltd. | Japan

Mr. Shohei Katsuya is a dedicated Researcher at the Advanced Technology Research Institute of Osaka Gas Co., Ltd., where he has been contributing to cutting-edge scientific advancements since April 2021. He holds a Master of Agriculture degree from Kyoto University, earned in March 2021, and has since developed a strong research focus on the physiological functions of beta-hydroxybutyrate (BHB). His work revolves around understanding how BHB influences metabolic regulation, ketone body pathways, and physiological responses related to obesity and visceral fat accumulation. As metabolic disorders continue to rise globally, his research addresses critical scientific questions with direct implications for human health, nutrition, and disease prevention. Shohei has played an active role in developing nutritional strategies aimed at improving metabolic outcomes, collaborating with academic institutions, and supporting multidisciplinary projects that advance metabolic health science. Between 2023 and 2025, Shohei has authored five peer-reviewed publications in reputable international journals, including Obesities, Journal of Nutritional Science and Vitaminology, Bioscience, Biotechnology, and Biochemistry, and Nutrition. These publications collectively reflect his commitment to scientific rigor and his growing influence in the fields of nutritional science and metabolic physiology. His research output has received 18 citations to date, according to Scopus metrics (as of November 2025), and his current h-index of 2 indicates early yet solid scholarly impact within a short timeframe. His contributions provide valuable insights into ketone-body-driven metabolic pathways, opening possibilities for new therapeutic and dietary approaches. Shohei’s research activities align strongly with the mission of advancing evidence-based nutrition and metabolic science, demonstrating originality, societal relevance, and a high level of research integrity. His projects emphasize translational potential—particularly in dietary interventions for visceral fat reduction—and reflect an understanding of both biochemical mechanisms and practical applications for health improvement. Through continuous collaboration with academic partners, Shohei has strengthened his ability to transform scientific concepts into meaningful innovations that address modern health challenges. His commitment to excellence, ethical research practice, and impactful scientific contribution make him a strong candidate for the Excellence in Research Award. Shohei declares that all information provided in this application is accurate and authentic to the best of his knowledge, and he remains fully committed to upholding the values and standards of the International Research Awards.

Profiles: Scopus | Orcid

Featured Publications

Aisyah, R., Katsuya, S., Miyata, K., Chen, Z., Horii, M., Kudo, A., Kumrungsee, T., Tsubota, J., & Yanaka, N. (2025). β-hydroxybutyrate attenuates diabetic renal and muscular pathologies in a streptozotocin-induced diabetic model. Nutrition, 112792. https://doi.org/10.1016/j.nut.2025.112792

Katsuya, S., Kawata, Y., Kawamura, Y., Kawamura, J., & Tsubota, J. (2025). Effect of d-β-hydroxybutyrate on sleep quality in healthy participants: A randomized, double-blind, placebo-controlled study. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbaf017

Katsuya, S., Kawata, Y., Sugimoto, M., Nishimura, T., & Tsubota, J. (2024). Determination of the safety of Halomonas sp. KM-1-derived d-β-hydroxybutyric acid and its fermentation-derived impurities in mice and Japanese adults. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae088

Ip, C.-H., Higuchi, H., Wu, C.-Y., Okuda, T., Katsuya, S., Ogawa, J., & Ando, A. (2024). Production of docosahexaenoic acid by a novel isolated Aurantiochytrium sp. 6-2 using fermented defatted soybean as a nitrogen source for sustainable fish feed development. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae035

Katsuya, S., Kawata, Y., Goto, T., & Tsubota, J. (2023). Daily intake of D-β-hydroxybutyric acid (D-BHB) reduces body fat in Japanese adult participants: A randomized, double-blind, placebo-controlled study. Journal of Nutritional Science and Vitaminology, 69(2), 121–129. https://doi.org/10.3177/jnsv.69.121

Manish Kumar | Bioinorganic Chemistry | Best Researcher Award | 13651

Dr. Manish Kumar | Bioinorganic Chemistry | Best Researcher Award 

Delhi University | India

Dr. Manish Kumar is a dedicated researcher and academician with a strong background in Inorganic Chemistry, currently based at the University of Delhi, India. He earned his Ph.D. in Inorganic Chemistry from the University of Delhi in March 2021, under the guidance of Dr. Dhanraj T. Masram, focusing on the synthesis and characterization of metal complexes based on quinolone derivatives and heterocyclic ligands for biological applications. His research spans coordination chemistry, organometallic chemistry, and bioinorganic chemistry, with special emphasis on the development of metal-based complexes as potential therapeutic agents. Dr. Kumar has an impressive academic foundation with an M.Sc. in Inorganic Chemistry from Hansraj College, University of Delhi, and a B.Sc. (Hons) in Chemistry from Dyal Singh College. Over the course of his research career, he has developed deep expertise in DNA/protein binding studies, cleavage analysis, and crystallization of metal complexes. He has hands-on experience with a variety of analytical instruments including UV-Vis, fluorescence spectrometry, CD spectroscopy, cyclic voltammetry, and gel electrophoresis techniques. He has authored 12 research publications in internationally reputed journals such as New Journal of Chemistry, Dalton Transactions, Inorganic Chimica Acta, Spectrochimica Acta Part A, and Inorganic Chemistry Frontiers. In addition, he has contributed two book chapters in recognized international publications, including one by John Wiley-Scrivener USA. His work has received increasing academic recognition, with a total of over 250+ citations (as of 2025), an h-index of 8, and an i10-index of 7 (please update with your exact Google Scholar/Scopus data). Dr. Kumar has actively participated in several national and international conferences, delivering oral and poster presentations, and has also served as a reviewer for journals like New Journal of Chemistry (RSC) and Applied Organometallic Chemistry (Wiley). He is a UPSC-qualified Chemist (2023) and also cleared the CSIR-NET (JRF & LS) and GATE examinations with top national ranks. In addition to his research contributions, Dr. Kumar has extensive teaching experience as a Guest Assistant Professor at the Department of Chemistry, University of Delhi (2021–2023), where he taught M.Sc. practicals and theory courses in Supramolecular Chemistry, and d- and f-block Elements, while also mentoring students in research-based laboratory courses. With strong academic credentials, a robust publication record, and excellent laboratory and teaching skills, Dr. Manish Kumar continues to explore frontiers in metal-based drug design and coordination chemistry, aiming to contribute to both scientific advancement and student development in the chemical sciences.

Profiles: Scopus

Featured Publications

Kumar, M., Lal, N., Luthra, P. M., & Masram, D. T. (2021). Exploring binding plus cleavage activities of nickel(II) complexes towards DNA and proteins. New Journal of Chemistry, 45(16), 6693–6708.

Kumar, M., Kumar, G., & Masram, D. T. (2020). Copper(II) complexes containing enoxacin and heterocyclic ligands: Synthesis, crystal structures and their biological perspectives. New Journal of Chemistry, 44(23), 8595–8613.

Kumar, G., Mogha, N. K., Kumar, M., & Masram, D. T. (2020). NiO nanocomposites/rGO as a heterogeneous catalyst for imidazole scaffolds with applications in inhibiting the DNA binding activity. Dalton Transactions, 49(6), 1963–1974.

Kumar, M., Kumar, G., Dadure, K. M., & Masram, D. T. (2019). Copper(II) complexes based on levofloxacin and 2N-donor ligands: Synthesis, crystal structures and in vitro biological evaluation. New Journal of Chemistry, 43(39), 15462–15481.

Kumar, G., Kant, A., Kumar, M., & Masram, D. T. (2019). Synthesis, characterization and kinetic study of metal-organic framework nanocomposite excipient used as extended release delivery vehicle for an antibiotic drug. Inorganica Chimica Acta, 496, 119036.

Kumar, M., Mogha, N. K., Kumar, G., Hussain, F., & Masram, D. T. (2019). Biological evaluation of copper(II) complex with nalidixic acid and 2,2′-bipyridine (bpy). Inorganica Chimica Acta, 490, 144–154.

Kumar, M., Kumar, G., Mogha, N. K., Jain, R., Hussain, F., & Masram, D. T. (2019). Structure, DNA/proteins binding, docking and cytotoxicity studies of copper(II) complexes with the first quinolone drug nalidixic acid and 2,2′-dipyridylamine. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 212, 94–104.

Kumar, M., & Masram, D. T. (2019). Evaluation of DNA, BSA, and HSA binding propensity of copper(II) complex with N-donor ligand 2,2’-dipyridylamine. Polyhedron, 157, 511–520.

Obinna Chukwuemeka | Biochemistry | Best Researcher Award |13170

Dr. Obinna Chukwuemeka | Biochemistry | Best Researcher Award 

Dr. Obinna Chukwuemeka, University of Calabar, Nigeria

Dr. Obinna Chukwuemeka is a distinguished scholar affiliated with the University of Calabar, Nigeria. His academic and research contributions focus on advancing knowledge in his field, fostering innovation, and addressing critical challenges in his area of expertise. As an educator and researcher, Dr. Chukwuemeka is dedicated to promoting academic excellence and sustainable development through impactful studies and mentorship.

Profile

Google Scholar

Scopus

Educational Qualification 📚

Dr. Obinna Chukwuemeka Godfrey embarked on his academic journey with a strong passion for biochemistry. He earned his BSc in Biochemistry with second-class honors from Michael Okpara University of Agriculture, Umudike, Nigeria. Building on this foundation, he pursued his MSc in Biochemistry, graduating with distinction from the same institution. His academic excellence and research prowess led him to pursue his PhD in Biochemistry, which he also completed with distinction.

Professional Endeavors 💼

Dr. Godfrey’s professional endeavors began as a Quality Assurance Officer/Lab Technician (Contract) at Guinness Nigeria PLC Aba Brewery, where he worked from 2014 to 2019. He then transitioned to academia, becoming a Lecturer 1 at the Department of Biochemistry, University of Calabar, Nigeria. Additionally, he served as a Visiting Lecturer at the Department of Biochemistry, Clifford University, Owerrinta, Abia State, Nigeria, in 2020.

Contributions and Research Focus 🔬

Dr. Godfrey’s research focus lies at the intersection of biochemistry, medicinal chemistry, and computational biology. He has made significant contributions to the understanding of the therapeutic properties of various compounds, including biflavonoids, Schiff base derivatives, and terpolymers. His research has explored the potential of these compounds in combating diseases such as malaria, urinary tract infections, and cancer.

Accolades and Recognition 🏆

Dr. Godfrey’s academic and research achievements have earned him recognition and accolades. He is a member of the Biochemical Society, London, the American Society for Biochemistry and Molecular Biology (ASBMB), and the Nigerian Society of Biochemistry and Molecular Biology (NSBMB). His research has been published in reputable international journals, including the Journal of Molecular Structure, Zeitschrift für Physikalische Chemie, and the Journal of the Indian Chemical Society.

Impact and Influence 🌐

Dr. Godfrey’s research has contributed significantly to the understanding of the therapeutic properties of various compounds. His work has the potential to inform the development of new drugs and therapies for diseases such as malaria, urinary tract infections, and cancer. His research has also been recognized internationally, with collaborations and citations from researchers around the world.

Legacy and Future Contributions 🔜

As a rising star in the field of biochemistry and medicinal chemistry, Dr. Godfrey’s future contributions are eagerly anticipated. His ongoing research projects, including the investigation of the therapeutic properties of various compounds, hold promise for breakthroughs in the treatment and prevention of diseases. His commitment to mentoring and teaching the next generation of researchers ensures that his legacy will continue to inspire and shape the field for years to come.

Publication Top Notes

Structural analysis, reactivity descriptors (HOMO-LUMO, ELF, NBO), effect of polar (DMSO, EtOH, H2O) solvation, and libido-enhancing potential of resveratrol by molecular docking

Author: EA Adindu, OC Godfrey, EI Agwupuye, BO Ekpong, DC Agurokpon, …
Journal: Chemical Physics Impact
Year: 2023
Author: CB Ubah, N Mujafarkani, A Sundaravadivelu, N Narendran, OC Godfrey, …
Journal: Molecular Structure
Year: 2024

Metals (Ga, In) encapsulated aluminum nitride nanotubes (AlNNTs) as nonenzymatic sensors for biomarker volatiles of liver cirrhosis: A computational study

Author: OC Godfrey, H Louis, AG Al-Sehemi, TE Gber, YN Kavil, OF Ede, FO Akor, …
Journal: Molecular Liquids
Year: 2023

Hexachlorobenzene (HCB) adsorption onto the surfaces of C60, C59Si, and C59Ge: Insight from DFT, QTAIM, and NCI

Author: OCG Mohsen D. Mohammadi, Hewa Y. Abdullah, Hitler Louis, Emmanuel E. Etim …
Journal: Chemical Physics Impact
Year: 2023